Technical / White Paper

Accelerating Time to IND with Pharma 4.0

Format: PDF file | Document type: Technical / White Paper | Promoted Content

This content is provided by Wheeler Bio, and any views and opinions expressed do not necessarily reflect those of

Accelerating Time to IND with Pharma 4.0

The future of the biopharmaceutical industry hinges on its adoption of 21st-century digital tools and automation. In this article, leadership from disruptive new biopharmaceutical CDMO Wheeler Bio discuss the benefits of forward-looking digitalization and collaboration in the industry. Following Pharma 4.0 principles, Wheeler Bio is working to integrate hardware, software, and biology to deliver a new tier of biomanufacturing quality, clinical timelines, and data transparency for emerging biotech companies.

Related resources from Wheeler Bio

Supplier info centre